List of works - Patricia R Blank

Attitudes of the General Public and General Practitioners in Five Countries towards Pandemic and Seasonal Influenza Vaccines during Season 2009/2010 ⬇️

scientific article published on October 11, 2012

Cost Effectiveness of Sucroferric Oxyhydroxide Compared with Sevelamer Carbonate in the Treatment of Hyperphosphataemia in Patients Receiving Dialysis, from the Perspective of the National Health Service in Scotland

scientific article published on 3 September 2015

Cost effectiveness of cytotoxic and targeted therapy for metastatic breast cancer: a critical and systematic review.

scientific article

Cost-effectiveness analysis of prognostic gene expression signature-based stratification of early breast cancer patients

scientific article

Cost-effectiveness of 13-valent pneumococcal conjugate vaccine in Switzerland

scientific article published on 20 April 2012

Current challenges in handling genetic data.

scientific article

Developments in influenza vaccination coverage in England, Scotland and Wales covering five consecutive seasons from 2001 to 2006.

scientific article

Disparities in influenza vaccination coverage rates by target group in five European countries: trends over seven consecutive seasons.

scientific article

Economic burden of symptomatic iron deficiency - a survey among Swiss women

article

Health economic assessment of ferric carboxymaltose in patients with iron deficiency and chronic heart failure based on the FAIR-HF trial: an analysis for the UK

scientific article

Herpes zoster vaccine: A health economic evaluation for Switzerland

scientific article published on 8 May 2017

Human epidermal growth factor receptor 2 expression in early breast cancer patients: a Swiss cost-effectiveness analysis of different predictive assay strategies.

scientific article published on 3 April 2010

Impact of European vaccination policies on seasonal influenza vaccination coverage rates: An update seven years later

scientific article published on 27 August 2018

Increasing influenza vaccination coverage in recommended population groups in Europe.

scientific article published on April 2009

Influenza vaccination coverage rates in Europe--covering five consecutive seasons (2001-2006) in five countries

scientific article published on September 2007

Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons.

scientific article

Influenza vaccination uptake and socioeconomic determinants in 11 European countries.

scientific article

Influenza vaccination: key facts for general practitioners in Europe-a synthesis by European experts based on national guidelines and best practices in the United Kingdom and the Netherlands

scientific article published on 03 August 2016

KRAS and BRAF mutation analysis in metastatic colorectal cancer: a cost-effectiveness analysis from a Swiss perspective.

scientific article

Personalized cancer medicine and the future of pathology.

scientific article published on 06 December 2011

Population access to new vaccines in European countries.

scientific article published on 28 April 2013

Potential health economic impact of intravenous iron supplementation to erythropoiesis-stimulating agent treatment in patients with cancer- or chemotherapy-induced anemia.

scientific article published on 15 September 2011

Reconstruction versus conservative treatment after rupture of the anterior cruciate ligament: cost effectiveness analysis ⬇️

scientific article published on November 19, 2011

Sozialer und ökonomischer Nutzen der Impfung gegen Influenza.

scientific article published on January 2017

The hypoxic transcriptome of the retina: identification of factors with potential neuroprotective activity

scientific article published on 01 January 2008

The use of the EVITA algorithm for clinical assessment of novel agents used in prostate cancer, metastatic melanoma, and systemic lupus erythematosus.

scientific article published on 27 May 2014

Trends in influenza vaccination coverage rates in Germany over six seasons from 2001/02 to 2006/07.

scientific article

Vaccination coverage rates in eleven European countries during two consecutive influenza seasons.

scientific article

List of works by Patricia R Blank

Attitudes of the General Public and General Practitioners in Five Countries towards Pandemic and Seasonal Influenza Vaccines during Season 2009/2010 ⬇️

Cost Effectiveness of Sucroferric Oxyhydroxide Compared with Sevelamer Carbonate in the Treatment of Hyperphosphataemia in Patients Receiving Dialysis, from the Perspective of the National Health Service in Scotland

Cost effectiveness of cytotoxic and targeted therapy for metastatic breast cancer: a critical and systematic review.

Cost-effectiveness analysis of prognostic gene expression signature-based stratification of early breast cancer patients

Cost-effectiveness of 13-valent pneumococcal conjugate vaccine in Switzerland

Current challenges in handling genetic data.

Developments in influenza vaccination coverage in England, Scotland and Wales covering five consecutive seasons from 2001 to 2006.

Disparities in influenza vaccination coverage rates by target group in five European countries: trends over seven consecutive seasons.

Economic burden of symptomatic iron deficiency - a survey among Swiss women

Health economic assessment of ferric carboxymaltose in patients with iron deficiency and chronic heart failure based on the FAIR-HF trial: an analysis for the UK

Herpes zoster vaccine: A health economic evaluation for Switzerland

Human epidermal growth factor receptor 2 expression in early breast cancer patients: a Swiss cost-effectiveness analysis of different predictive assay strategies.

Impact of European vaccination policies on seasonal influenza vaccination coverage rates: An update seven years later

Increasing influenza vaccination coverage in recommended population groups in Europe.

Influenza vaccination coverage rates in Europe--covering five consecutive seasons (2001-2006) in five countries

Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons.

Influenza vaccination uptake and socioeconomic determinants in 11 European countries.

Influenza vaccination: key facts for general practitioners in Europe-a synthesis by European experts based on national guidelines and best practices in the United Kingdom and the Netherlands

KRAS and BRAF mutation analysis in metastatic colorectal cancer: a cost-effectiveness analysis from a Swiss perspective.

Personalized cancer medicine and the future of pathology.

Population access to new vaccines in European countries.

Potential health economic impact of intravenous iron supplementation to erythropoiesis-stimulating agent treatment in patients with cancer- or chemotherapy-induced anemia.

Reconstruction versus conservative treatment after rupture of the anterior cruciate ligament: cost effectiveness analysis ⬇️

Sozialer und ökonomischer Nutzen der Impfung gegen Influenza.

The hypoxic transcriptome of the retina: identification of factors with potential neuroprotective activity

The use of the EVITA algorithm for clinical assessment of novel agents used in prostate cancer, metastatic melanoma, and systemic lupus erythematosus.

Trends in influenza vaccination coverage rates in Germany over six seasons from 2001/02 to 2006/07.

Vaccination coverage rates in eleven European countries during two consecutive influenza seasons.